156 related articles for article (PubMed ID: 36898362)
1. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Moses KA; Sprenkle PC; Bahler C; Box G; Carlsson SV; Catalona WJ; Dahl DM; Dall'Era M; Davis JW; Drake BF; Epstein JI; Etzioni RB; Farrington TA; Garraway IP; Jarrard D; Kauffman E; Kaye D; Kibel AS; LaGrange CA; Maroni P; Ponsky L; Reys B; Salami SS; Sanchez A; Seibert TM; Shaneyfelt TM; Smaldone MC; Sonn G; Tyson MD; Vapiwala N; Wake R; Washington S; Yu A; Yuh B; Berardi RA; Freedman-Cass DA
J Natl Compr Canc Netw; 2023 Mar; 21(3):236-246. PubMed ID: 36898362
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Kim S; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Moses KA; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenkle P; Vickers AJ; Wake R; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 May; 14(5):509-19. PubMed ID: 27160230
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Giri VN; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shanefelt TM; Vickers AJ; Wake R; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 Sep; 12(9):1211-9; quiz 1219. PubMed ID: 25190691
[TBL] [Abstract][Full Text] [Related]
4. NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenke P; Vickers AJ; Wake R; Shead DA; Freedman-Cass D
J Natl Compr Canc Netw; 2015 Dec; 13(12):1534-61. PubMed ID: 26656522
[TBL] [Abstract][Full Text] [Related]
5. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer EM; Srinivas S; Adra N; An Y; Barocas D; Bitting R; Bryce A; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Netto G; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Teply BA; Tward J; Valicenti R; Wong JK; Berardi RA; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1288-1298. PubMed ID: 36509074
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer early detection clinical practice guidelines in oncology.
Babaian RJ; Partin AW;
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S42-55. PubMed ID: 19795575
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer early detection. Clinical practice guidelines in oncology.
National Comprehensive Cancer Network
J Natl Compr Canc Netw; 2004 May; 2(3):190-207. PubMed ID: 19795604
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
Butler SS; Muralidhar V; Zhao SG; Sanford NN; Franco I; Fullerton ZH; Chavez J; D'Amico AV; Feng FY; Rebbeck TR; Nguyen PL; Mahal BA
Cancer; 2020 Feb; 126(4):717-724. PubMed ID: 31794057
[TBL] [Abstract][Full Text] [Related]
9. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
Carroll PH; Mohler JL
J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
[TBL] [Abstract][Full Text] [Related]
10. The Case for Tailored Prostate Cancer Screening: An NCCN Perspective.
McDonald ML; Parsons JK
J Natl Compr Canc Netw; 2015 Dec; 13(12):1576-83. PubMed ID: 26656524
[TBL] [Abstract][Full Text] [Related]
11. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
Schaeffer E; Srinivas S; Antonarakis ES; Armstrong AJ; Bekelman JE; Cheng H; D'Amico AV; Davis BJ; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Horwitz EM; Ippolito JE; Kuettel MR; Lang JM; McKay R; McKenney J; Netto G; Penson DF; Pow-Sang JM; Reiter R; Richey S; Roach Iii M; Rosenfeld S; Shabsigh A; Spratt DE; Teply BA; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2021 Feb; 19(2):134-143. PubMed ID: 33545689
[TBL] [Abstract][Full Text] [Related]
12. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?
Carroll PR; Vickers AJ
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):768-71. PubMed ID: 24853213
[TBL] [Abstract][Full Text] [Related]
13. The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J
J Urol; 2020 May; 203(5):910-917. PubMed ID: 31825297
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer, version 2.2014.
Mohler JL; Kantoff PW; Armstrong AJ; Bahnson RR; Cohen M; D'Amico AV; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Kane CJ; Kawachi MH; Kuettel M; Kuzel TM; Lee RJ; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Raben D; Richey S; Roach M; Rohren E; Rosenfeld S; Schaeffer E; Small EJ; Sonpavde G; Srinivas S; Stein C; Strope SA; Tward J; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 May; 12(5):686-718. PubMed ID: 24812137
[TBL] [Abstract][Full Text] [Related]
15. Management of an increasing prostate-specific antigen level after negative prostate biopsy.
Shinohara K; Nguyen H; Masic S
Urol Clin North Am; 2014 May; 41(2):327-38. PubMed ID: 24725493
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Mohler JL; Armstrong AJ; Bahnson RR; Boston B; Busby JE; D'Amico AV; Eastham JA; Enke CA; Farrington T; Higano CS; Horwitz EM; Kantoff PW; Kawachi MH; Kuettel M; Lee RJ; MacVicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Roach M; Rohren E; Rosenfeld S; Srinivas S; Strope SA; Tward J; Twardowski P; Walsh PC; Ho M; Shead DA
J Natl Compr Canc Netw; 2012 Sep; 10(9):1081-7. PubMed ID: 22956807
[TBL] [Abstract][Full Text] [Related]
17. NCCN Guidelines Updates: Management of Prostate Cancer.
Mohler JL; Antonarakis ES
J Natl Compr Canc Netw; 2019 May; 17(5.5):583-586. PubMed ID: 31117038
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of 4Kscore
de la Calle CM; Fasulo V; Cowan JE; Lonergan PE; Maggi M; Gadzinski AJ; Yeung RA; Saita A; Cooperberg MR; Shinohara K; Carroll PR; Nguyen HG
J Urol; 2021 Feb; 205(2):452-460. PubMed ID: 32897802
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience.
Mouraviev V; Verma S; Kalyanaraman B; Zhai QJ; Gaitonde K; Pugnale M; Donovan JF
J Endourol; 2013 Jul; 27(7):820-5. PubMed ID: 22966987
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.
Wood DE; Kazerooni EA; Aberle D; Berman A; Brown LM; Eapen GA; Ettinger DS; Ferguson JS; Hou L; Kadaria D; Klippenstein D; Kumar R; Lackner RP; Leard LE; Lennes IT; Leung ANC; Mazzone P; Merritt RE; Midthun DE; Onaitis M; Pipavath S; Pratt C; Puri V; Raz D; Reddy C; Reid ME; Sandler KL; Sands J; Schabath MB; Studts JL; Tanoue L; Tong BC; Travis WD; Wei B; Westover K; Yang SC; McCullough B; Hughes M
J Natl Compr Canc Netw; 2022 Jul; 20(7):754-764. PubMed ID: 35830884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
